A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations
Novartis
Novartis
St. Justine's Hospital
Eastern Cooperative Oncology Group
The Children's Hospital of Zhejiang University School of Medicine
Essen Biotech
University of Nebraska
Adela, Inc
Memorial Sloan Kettering Cancer Center
University Health Network, Toronto
Children's Oncology Group
Massive Bio, Inc.
UNC Lineberger Comprehensive Cancer Center
Incyte Corporation
Barbara Ann Karmanos Cancer Institute
Region Skane
Rigshospitalet, Denmark
Tempus AI
Children's Oncology Group